ReviewRheumatology international2026
Increased vein wall thickness in Behçet's disease: from intravascular mechanical stress to vascular remodelling and venous thrombosis.
Review in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behçet’s disease (BD) is a chronic, multisystem inflammatory disorder characterized by recurrent oral ulcers, genital ulcers, and uveitis, together with various manifestations. Vascular involvement occurs in 25–30% of BD patients. Recent studies on BD have remarkably claimed that even Behçet patients without vascular problems exhibit increased vein wall thickness (VWT). Researchers suggested that this increase in VWT may have a diagnostic value for BD. However, the mechanisms responsible for this process and its clinical significance remain unclear. In this Perspective article, we describe how aberrant responses to mechanical stress, such as intravascular pressure, can lead to venous wall remodeling and increased VWT. Specifically, we will discuss the process from vascular remodeling to thrombosis, examining the roles of Piezo1 mechanotransducers, activated adventitial cells, and secreted angiogenic factors and cytokines. In this process, the possible role of innate immunity and adaptive immune activation will be discussed in the context of the pathogenesis of MHC-I-opathy group diseases. According to our hypothesis, the activation of fibroblasts and other immune cells in the adventitia primarily initiates an adventitial inflammation. Cytokines and angiogenic factors produced from macrophages and fibroblasts during this inflammatory process lead to proliferation in vasa vasorum (VV) alongside a fibroinflammatory response. In this phase, which can be explained as a remodeling phase, VWT increases. When the vasa vasorum that are fragile and unable to form collateral are inflamed, damage and ischemia develop in the vascular wall. These events disrupt endothelial integrity and lead to deep venous thrombosis (DVT). Understanding these changes can aid in the development of preventative strategies to mitigate the onset of DVT in BD patients.
Indexed as
Identifiers
41489744What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.